Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
2seventy bio (TSVT)
NASDAQ:TSVT
2seventy bio (TSVT) Stock Price & Analysis
250 Followers
TSVT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.54 - $10.89
Previous Close$4.44
Volume544.21K
Average Volume (3M)595.69K
Market Cap
$228.24M
Enterprise Value$267.92M
Total Cash (Recent Filing)$216.99M
Total Debt (Recent Filing)$256.67M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Aug 07, 2024EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.34
Shares Outstanding51,405,419
10 Day Avg. Volume385,165
30 Day Avg. Volume595,686
Standard Deviation0.32
R-Squared0.09
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.64
Price to Sales (P/S)3.45
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.70
Enterprise Value/Gross Profit3.21
Enterprise Value/Ebitda-1.37
Forecast
1Y Price Target
$6.00Price Target Upside25.79% Upside
Rating ConsensusHold
Number of Analyst Covering5
2seventy bio News
PremiumCompany Announcements
2seventy bio Strikes Strategic Gene Therapy Deal with Novo Nordisk
PremiumCompany Announcements
2seventy bio’s Board Elections and Financial Oversight Update
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe target price for the stock has been raised, indicating a positive outlook on the company's financial performance.
Market ExpansionThe acute supply shortage for Abecma will likely be alleviated with the addition of manufacturing facilities.
Regulatory ApprovalFDA approved Abecma for use in earlier lines of therapy, expanding its market potential.
Bears Say
Competitive DynamicsAbecma is losing market share in the face of increasing competition from both Carvykti and bispecifics.
Cost StructureCost structure and margin profile are concerning, with margin improvement dependent on greater sales volumes.
Pipeline And CatalystsThe company has limited pipeline optionality and value-driving catalysts after the recent sale of its pipeline to REGN.
---
Ownership Overview
50.49% Insiders
19.90% Mutual Funds
18.32% Other Institutional Investors
11.29% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TSVT FAQ
What was 2seventy bio’s price range in the past 12 months?
2seventy bio lowest stock price was $1.53 and its highest was $10.89 in the past 12 months.
What is 2seventy bio’s market cap?
Currently, no data Available
When is 2seventy bio’s upcoming earnings report date?
2seventy bio’s upcoming earnings report date is Aug 07, 2024 which is in 16 days.
How were 2seventy bio’s earnings last quarter?
2seventy bio released its earnings results on May 08, 2024. The company reported -$1.01 earnings per share for the quarter, missing the consensus estimate of -$0.746 by -$0.264.
Is 2seventy bio overvalued?
According to Wall Street analysts 2seventy bio’s price is currently Undervalued.
Does 2seventy bio pay dividends?
2seventy bio does not currently pay dividends.
What is 2seventy bio’s EPS estimate?
2seventy bio’s EPS estimate is -$0.5.
How many shares outstanding does 2seventy bio have?
2seventy bio has 51,405,420 shares outstanding.
What happened to 2seventy bio’s price movement after its last earnings report?
2seventy bio reported an EPS of -$1.01 in its last earnings report, missing expectations of -$0.746. Following the earnings report the stock price went down -9.677%.
Which hedge fund is a major shareholder of 2seventy bio?
Among the largest hedge funds holding 2seventy bio’s share is Baker Bros Advisors LP. It holds 2seventy bio’s shares valued at 13M.
---
2seventy bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$6.00 (25.79% Upside)
$6.00 (25.79% Upside)
Blogger Sentiment
Bullish
TSVT Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 946.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.56%
12-Months-Change
Fundamentals
Return on Equity
-73.34%
Trailing 12-Months
Asset Growth
-31.17%
Trailing 12-Months
Company Description
2seventy bio
2seventy bio Inc is primarely in the business of pharmaceutical preparations.
---
TSVT Earnings Call
Q1 2024
0:00 / 0:00
---
TSVT Stock 12 Month Forecast
Average Price Target
$6.00
▲(25.79% Upside)
Technical Analysis
Best Analysts Covering TSVT
1 Year
1 Year Success Rate
2/17 ratings generated profit
1 Year Average Return
-46.52%
reiterated a buy rating 2 months ago
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -46.52% per trade.
---